CDC postpones session on ‘ preparing for the unthinkable ’ : a nuclear blast
The Centers for Disease Control and Prevention has rescheduled a teaching session on the public health response to a nuclear blast that was supposed to take place Tuesday. The session, which was to feature presentations from U.S. experts on public health preparedness and response and radiation, included a session titled "Preparing for the Unthinkable." The […]Related:First treatment approved for breast cancer with BRCA genetic mutationCDC says, ‘There’s lots of flu in lots of places.’ And it’s not going away anytime soon.FDA warns against giving kids cough and cold medicines with codeine or hydrocodon...
Source: Washington Post: To Your Health - January 12, 2018 Category: Consumer Health News Source Type: news
FDA revises label on opioid cold meds to limit pediatric use
The FDA this week announced that it’s mandating labeling changes to cut the use of prescription opioid cough and cold medicines containing codeine or hydrocodone in kids under 18 years of age.
The agency wrote in a statement that the risks of these drugs outweigh their potential benefits for children. The medications will also receive an expanded Boxed Warning notifying users about the risks of abuse, addiction and death.
Get the full story at our sister site, Drug Delivery Business News.
The post FDA revises label on opioid cold meds to limit pediatric use appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - January 12, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Food & Drug Administration (FDA) Pediatrics Pharmaceuticals Respiratory Source Type: news
Prescription Opioid Cough and Cold Medicines Restricted to Adult Use
Prescription cough and cold medications containing opioids like codeine and hydrocodone will no longer be indicated for patients under age 18, the FDA announced on... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - January 12, 2018 Category: Primary Care Source Type: news
FDA strengthens warning on opioid cold medicine
The FDA is now requiring changes to the safety labeling on prescription cough and cold medicines containing codeine or hydrocodone. The changes are to indicate that they shouldn't be given to children younger than 18 due to serious risks. (Source: CNN.com - Health)
Source: CNN.com - Health - January 11, 2018 Category: Consumer Health News Source Type: news
FDA Puts New Limits on Opioids in Kids ’ Cough Meds
(MedPage Today) -- Label changes for products containing hydrocodone and codeine (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - January 11, 2018 Category: Psychiatry Source Type: news
FDA warns against giving kids cough and cold medicines with codeine or hydrocodone
The Food and Drug Administration warned Thursday that children and adolescents should not be prescribed cough and cold medicines containing codeine and hydrocodone because of serious safety risks posed by the opioid ingredients. The agency said it is requiring manufacturers to change the wording on their labels to make clear that such products should not be used for […]Related:New study on abortion pill shows high success, low rate of complicationsHe was 21 and fit. He tried to push through the flu — and it killed him.The rural-urban sex divide in three simple charts (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - January 11, 2018 Category: Consumer Health News Source Type: news
No Opioid Cough Meds in Children Under 18, FDA Says No Opioid Cough Meds in Children Under 18, FDA Says
Prescription cough and cold medicines containing codeine or hydrocodone are no longer indicated in any pediatric population and will be labeled for use only in adults aged 18 years and older, the FDA says.News Alerts (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 11, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Alert Source Type: news
FDA acts to protect kids from serious risks of opioid ingredients contained in some prescription cough and cold products by revising labeling to limit pediatric use
The U.S. Food and Drug Administration announced today that it is requiring safety labeling changes to limit the use of prescription opioid cough and cold medicines containing codeine or hydrocodone in children younger than 18 years old because the serious risks of these medicines outweigh their potential benefits in this population. After safety labeling changes are made, these products will no longer be indicated for use to treat cough in any pediatric population and will be labeled for use only in adults aged 18 years and older. Labeling for the medications also is being updated with additional safety information for adu...
Source: Food and Drug Administration - January 11, 2018 Category: American Health Source Type: news
Are ibuprofen plus acetaminophen as good as opioids in treating acute extremity pain
3.5 out of 5 stars
Effect of a Single Dose of Oral Opioid and Nonopioid Analgesics on Acute Extremity Pain in the Emergency Department: A Randomized Clinical Trial. Chang AK et al. JAMA 2017;318:1661-1667.
Abstract
As Dr. Demetrios Kyriacou points out in a must-read editorial accompanying this paper, a growing body of evidence clearly indicates that even short-term opioid use for painful injuries or procedures carries a significant risk of leading to chronic use and potential abuse. We are now realizing the importance of avoiding even limited use of drugs such as oxycodone and hydrocodone in opioid-naive patients, if at ...
Source: The Poison Review - November 22, 2017 Category: Toxicology Authors: Leon Gussow Tags: Medical acute pain analgesic emergency department opioid Source Type: news
Over-The-Counter Pain Relievers Worked As Well As Opioids In New Study
CHICAGO (AP) — Emergency rooms are where many patients are first introduced to powerful opioid painkillers, but what if doctors offered over-the-counter pills instead? A new study tested that approach on patients with broken bones and sprains and found pain relievers sold as Tylenol and Motrin worked as well as opioids at reducing severe pain.
The results challenge common ER practice for treating short-term, severe pain and could prompt changes that would help prevent new patients from becoming addicted.
The study has limitations: It only looked at short-term pain relief in the emergency room and researchers didn’t...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - November 7, 2017 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Local News Confronting The Crisis opioid crisis Source Type: news
Hycodan (Hydrocodone Bitartrate and Homatropine Methylbromide) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 6, 2017 Category: Drugs & Pharmacology Source Type: news
Lortab Elixir (Hydrocodone Bitartrate and Acetaminophen Oral Solution) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 31, 2017 Category: Drugs & Pharmacology Source Type: news
Lortab 2.5 (Hydrocodone Bitartrate and Acetaminophen Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 31, 2017 Category: Drugs & Pharmacology Source Type: news
Lupin launches pain relieving generic tablets in US
Lupin's product is a generic version of Allergan Sales LLC's Norco tablets in the same strengths and is indicated for relief of moderate to moderately severe pain. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 10, 2017 Category: Pharmaceuticals Source Type: news
